2mg semaglutide to tirzepatide Subcutaneously administered vs for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Semaglutide to Tirzepatide Dosing :

As more studies are being published, more evidence points to the medications protective effects against developing any AMD in patients who do not have any AMD at baseline

Among these, retatrutide, a GIP/GLP-1/glucagon receptor triagonist administered via weekly injections, made its debut at the recent 83rd Scientific Session of the American Diabetes Association

Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)

Competitive Landscape Novo Nordisk and Eli Lilly are expected to maintain leadership in the obesity therapeutics market through the late 2020s